Background: Intracoronary imaging is an important tool for guiding decision making in the cardiac catheterization laboratory.
Introduction
Coronary angiography is considered the gold standard for the assessment of coronary artery disease. 1 Cardiologists perform millions of coronary angiograms annually worldwide. 2 Angiography is a 2-dimensional lumenogram of a complex 3-dimensional arterial structure; therefore, it is limited in providing accurate diagnostic information. An angiogram using multiple orthogonal views with visual estimation can provide information about a patient's coronary artery anatomy; however, this approach has several limitations due to inherent operator variability, which can lead to wide differences in interpretation of stenosis severity obtained from angiography in comparison to non-invasive imaging, expert core lab assessment, computer assisted measurements and autopsy comparisons. 3, 4 Though conventional coronary angiography is universally available and has good spatial and temporal resolution, it is limited in its ability to provide anatomical intravascular data and offers no insight into the physiologic correlation of the disease process. 1, 5 These shortcomings are most obvious in challenging situations; for instance, coronary artery calcification is underdiagnosed with angiography in as many as half the cases compared to intravascular ultrasound (IVUS). 3 Intracoronary imaging can help reduce the high intra-and inter-observer variability in the interpretation of stenosis severity and morphology of lesions that exists with angiographic assessment. 3 The technology provides precise and computerized measurements that help guide the decision-making process and reduces the variability in reporting. 6, 7 Intravascular imaging (IVI) can provide detailed information about vessel anatomy, extent and severity of the disease process, plaque morphology and precise vessel sizing for stent selection (Fig. 1 ). This information helps guide decision making and facilitates revascularization with percutaneous coronary interventions (PCI).
Modern advances with IVI have made the technology user-friendly and available for routine use in the cardiac catheterization laboratory. 8 Its use is of particular importance when treating complex higher risk indicated patients including for treatment decisions involving the left main stem and bifurcation disease. 4, 5, 9, 10 Adjunctive IVI can help us understand the mechanisms underlying stent failures. Despite the well-established role of IVI and innovations in technology, the everyday use of these modalities remains low worldwide.
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IVUS
IVUS is a sound-based technology that uses a specially designed catheter with an ultrasound probe to visualize intracoronary anatomy. 11 IVUS has been in use for more than half a century; its clinical utility has been validated in multiple randomized trials, and there are ongoing studies demonstrating the role of IVUS in improving clinical outcomes. 12 Real-time 360°cross-sectional images are obtained with IVUS, providing additional information and enhancing what is known from the lumen contours obtained by angiography. Detailed information in regard to the lumen, vessel size and plaque morphology can be valuable in the decision-making process. IVUS has the capacity to provide information on perivascular structures (perivascular damage) due to higher penetration power. IVUS can be used at any stage of the procedure. As part of a diagnostic assessment, IVUS can help to assess the plaque morphology, selecting the stent sizing based on lumen dimensions and selecting the precise length of a stent. During the procedure IVUS can confirm stent expansion and maximal luminal gain. Postprocedure imaging can help identify possible complications including dissections, under-expansion, malapposition, tissue protrusion and hematomas. Large-scale data from randomized trials have demonstrated that an IVUS-guided revascularization strategy compared with angiography-guided PCI can lead to improved clinical outcomes. 13 The Impact of Intravascular Ultrasound Guidance on Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL) randomized, multicenter trial was conducted in 1 400 patients with long coronary lesions (implanted stent ≥28 mm in length) and demonstrated that IVUSguided everolimus-eluting stent implantation, compared with angiography-guided stent implantation, resulted in a significantly lower rate of the composite endpoint of major adverse cardiac events at 1 year.
14 An in-depth review by Mintz. demonstrated the importance of imaging-guided revascularization in its review of nine randomized trials and 30 registry studies comparing IVUS-guided DES implantation with conventional angiographic guidance. 13 Specifically IVUS guidance was associated with a reduction in adverse events in all of the nine meta-analyses to date on this topic and was a cost-effective strategy. The Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study was a large study that included a pre-specified substudy that demonstrated the benefit of utilization of IVUS therapy in the 3349 (39%) patients treated with IVUSguided PCI. 7 Utilization of IVUS changed the PCI strategy in 74% of cases. Not only did IVUS impact decision making at the time of PCI, but the changes led to improved clinical outcomes compared with angiographic guidance. At 1 year, there was a significant reduction in definite/probable stent thrombosis (0.52% versus 1.04%, P = 0.003) and MI (2.5% versus 3.7%, P = 0.004) as well as the composite of major adverse cardiac events (3.1% versus 4.7%, P = 0.002).
The utility of IVUS has been recognized by various cardiac societies and recommended in the decisionmaking process in the cardiac catheterization laboratory. The use of IVUS has been encouraged in the assessment of intermediate lesions, for guiding stent implantation, and for determining the cause of stent thrombosis (Table 1) .
Guideline updates now include a new class IIa recommendation that supports using IVUS for the assessment of angiographically indeterminate left main coronary artery disease (Table 2) . Table 2 Current guideline recommendations for use of intravascular ultrasound and optical coherence tomography.
Serial surveillance with IVUS to monitor intimamedia thickness post-heart transplantation has also been included in the recommendations for 4-6 weeks post-cardiac transplant and at 1 year follow-up. 18 Another benefit of IVUS is with high-risk groups including patients with renal insufficiency undergoing percutaneous revascularization; in these patients, IVUS guidance can help reduce the volume of contrast administered. 19 IVUS-guided PCI has been used to develop a 'zero contrast' PCI strategy to treat patients at high risk of developing contrast-induced nephropathy. 20 IVUS can also be useful in cases of apparently normal coronary arteries on angiography.
Patients presenting with chest pain and positive noninvasive testing with discordant findings on angiography should undergo further evaluation with IVUS to exclude the presence of occult disease or clinical significance of an anomalous origin of a coronary artery. 21 Lastly, in the setting of acute emergencies in patients presenting with acute chest pain, IVUS can facilitate the diagnoses of acute aortic and coronary dissections. 22 
Optical coherence tomography
Optical coherence tomography (OCT) is a newer intracoronary imaging modality in comparison to IVUS. Naohiro Tanno and James G. Fujimoto developed this technology during the 1990s with initial ophthalmologic applications that led to the first OCT-based imaging catheter used in a coronary artery, with the first in-man report published in 2001. 23 This light-based technology has differences in comparison to sound-based IVUS. 24 OCT has higher axial resolution of 10-15 μm in contrast to the 150-200 μm resolution achieved with conventional IVUS catheters. 25 The high resolution helps delineate the three layers of an arterial wall and can differentiate between different tissue characteristics, providing detailed assessment for dissection, tissue prolapse, thrombi and stent apposition. 26 While OCT has higher resolution, the penetration is lower compared with IVUS. To obtain images, OCT requires displacement of blood from the segment being evaluated during imaging acquisition. While initially achieved by proximal balloon occlusion with time-domain OCT, in contemporary practice this is routinely achieved by contrast injection using frequency domain-OCT.
The unique features of OCT offer the ability to identify a very thin fibrous cap covering the lipid core and can potentially be used to predict future coronary events by identifying vulnerable plaques. 27 Compared with IVUS, which uses ultrasound technology and cannot penetrate calcium, OCT can assess the depth of calcium in a coronary lesion. [28] [29] [30] [31] This insight can alter patient management, as the operator can appropriately determine the need for lesion preparation and the use of atherectomy if indicated. OCT can improve PCI results with the precise and accurate information it provides, identifying the ideal landing zones for a stent and aiding the selection of appropriate stent sizing. One of the particular advantages of this technology is to provide detailed information during cases of stent failure to help understand the mechanism of failure. [32] [33] [34] Small thrombi that may be missed by angiography or IVUS can be detected by OCT. The resolution of OCT can also provide detailed lesion assessment, identifying the etiology of restenosis, by helping to determine if restenosis is focal or diffuse, and detecting the presence of neo-intimal thickening, microvessels, stent under-expansion and intraluminal calcification. 32, 33, 35 Knowledge of the characteristics and morphology of in-stent restenosis influences the subsequent management, which can vary widely to include a change in antiplatelet therapy, laser atherectomy or brachytherapy.
The CLI-OPCI study demonstrated that an OCTguided strategy changed the decision-making process in 35% of cases. OCT-guided stent implantation reduced mortality and MI at 1 year. The CLI-OPCI study also demonstrated that select patients with STelevation MI could be identified who could be treated with thrombus aspiration alone based on an OCT finding of plaque erosion rather than fibrous cap rupture. 36 The clinical safety of OCT was demonstrated in the Does Optical Coherence Tomography Optimize Results of Stenting (DOCTORS) study, wherein 240 patients presenting with non-ST-elevation MI were randomized to either OCT-guided PCI or angiography-guided PCI. The DOCTORS study found that OCT did not increase periprocedural complications, type 4a MI or acute kidney injury. OCT-guided PCI was associated with higher postprocedure FFR than PCI guided by angiography alone. 37 In the EROSION study, a proof of concept study, patients with residual stenosis <70% and plaque erosion identified on OCT in the setting of ACS, were treated with anti-thrombotic therapy without stenting. OCT imaging helped to determine in which patients stenting could safely be avoided. 38 To determine the ideal OCT-based stent sizing strategy, the ILUMIEN III: OPTIMIZE PCI study randomized 450 patients to IVUS-guided, OCTguided or angiography-guided PCI. 26 The ILUMIEN III trial found that an external elastic lamina-based stent optimization strategy was safe and resulted in similar minimum stent area to that of IVUS-guided PCI. There was a trend toward benefit of OCT over angiography guidance. A number of inherent limitations of OCT technology exist, as it requires the displacement of blood for adequate visualization. There are some difficulties obtaining the optimal image quality in cases of large diameter or aneurysmal vessels and in aorto-ostial lesions. As contrast is traditionally used to displace blood, OCT is often avoided in patients with renal failure as there are risks of contrast-induced kidney injury. Alternative non-contrast based flush agents are being evaluated in clinical studies for this patient population.
OCT is a safe and effective intracoronary modality used in cardiac catheterization laboratory that has been studied in multiple large-scale studies with a favorable safety profile. 39 There are ongoing clinical trials to demonstrate the impact of this technology in improving long-term clinical outcomes. 26 As further data is published, insights into the economic impact of OCT can be ascertained.
We recommend an algorithmic approach with IVI for comprehensive evaluation of coronary lesions (Fig. 2) . Use of IVI both pre-and post-PCI can optimize results. Pre-PCI lesion assessment can determine the plaque morphology and provide guidance on when lesion preparation is needed. IVI provides measurements of the lesion length and vessel dimensions guiding stent selection. This can result in fewer stents used as well as an increased likelihood of appropriate stent sizing. 7, 26 Post-PCI imaging is critical to confirm adequate stent expansion and exclude the presence of significant edge dissections or hematomas. When cases of stent failure are encountered, IVI is particularly important to determine the mechanism of stent failure. Determining the etiology of stent failure will impact how the patient is subsequently treated.
Areas of controversy
Low utilization of IVI in routine practice is often explained by the following criticisms: (i) IVI is too complicated to obtain and interpret, (ii) results are already good enough with modern equipment and techniques, (iii) IVI is unlikely to significantly change patient management, (iv) IVI is too expensive, (v) IVI takes too much time and (vi) IVI involves excessive risk. These issues can all be overcome by an understanding of the different technologies available and interpretation of the images (Table 3 ).
An algorithmic approach can allow an interventional cardiologist to incorporate IVI into his or her daily practice while individualizing therapy and tailoring treatment to each patient.
Growing points
As costs decline for IVI tools with improved reimbursement, utilization may improve. Additionally, further availability and integration into existing catheterization laboratory systems can improve utilization. Software including co-registration with angiography can improve diagnostic accuracy and utility of the data obtained with IVI.
Areas timely for developing research
There is large-scale evidence for utility of IVUS in clinical practice with a large number of trials currently ongoing. Clinical research interest in OCT is profound as well, with clinical studies underway to assess how best to incorporate OCT to improve the clinical outcomes for patients. The beneficial clinical role of OCT-guided therapy for assessment of plaque morphology and stent optimization is planned to be evaluated in the ILUMIEN IV multicenter trial.
Studies currently in progress include OPTICO-ACS (NCT03129503), which will assess the in vivo characterization of the ACS-causing 'culprit lesion Progression by Optical Coherence Tomography Combined With Intravascular Ultrasound (NCT01023607).
Conclusions
Modern x-ray angiography is a valuable tool in the cardiac catheterization laboratory to obtain images of coronary arteries. There are inherent limitations of this 2-dimensional technique and adjunctive intravascular techniques (IVUS and OCT) provide precise and detailed data of the 3-dimensional coronary artery tree. Hurdles of procedure-related cost and time are overcome by the benefits gained with IVI. A number of randomized trials are ongoing evaluating the impact of intracoronary imaging on long-term clinical outcomes. Combining an algorithmic approach to IVI with sound clinical judgment can improve the decision-making process and can help improve the clinical outcomes.
